高表达MMP2的成纤维细胞通过CD100调控CD8+ T细胞驻留与银屑病炎症
该研究探讨银屑病中成纤维细胞及MMP2-CD100轴对炎症的调控作用。采用免疫荧光、单细胞转录组测序等技术,发现可溶性CD100在皮损和外周血中显著上调,高表达MMP2的成纤维细胞促进CD8+ T细胞膜CD100脱落并上调CD103,增强CD8+ T细胞驻留,从而放大炎症;MMP2和CD100抑制剂在咪喹莫特诱导的银屑病模型中有效减轻炎症。
要点
- 可溶性CD100在银屑病皮损和外周血中显著上调,通过sCD100-PLXNB2轴放大炎症。
- 高表达MMP2的成纤维细胞促进CD8+ T细胞膜CD100脱落并上调CD103,增强T细胞驻留。
- MMP2和CD100抑制剂在咪喹莫特诱导的银屑病模型中有效减轻炎症。
核心结论
- 高表达MMP2的成纤维细胞在银屑病炎症放大和复发中起关键作用。
- 这些成纤维细胞通过促进CD8+ T细胞膜CD100脱落及上调CD103,增强CD8+ T细胞驻留,经CD100-PLXNB2轴加剧炎症。
研究设计与样本
- 采用免疫荧光、酶联免疫吸附试验、单细胞转录组测序、细胞相互作用分析及定量逆转录聚合酶链反应评估CD100表达与功能。
- 用磁珠分离银屑病患者CD8+ T细胞,研究MMP2对其膜CD100表达的调控。
- 利用单细胞转录组测序、空间转录组测序、模拟时间分析、免疫荧光和流式细胞术确定MMP2来源及其对CD103+ CD8+ T细胞的影响。
- 在体内使用MMP2和CD100抑制剂对咪喹莫特诱导的银屑病模型进行验证。
主要发现
- 可溶性CD100在银屑病皮损和外周血中显著上调,通过sCD100-PLXNB2轴促进角质形成细胞、成纤维细胞和内皮细胞产生炎症细胞因子。
- 高表达MMP2的成纤维细胞通过促进CD8+ T细胞膜CD100脱落加剧银屑病症状。
- 成纤维细胞与CD8+ T细胞共培养时增强CD8+ T细胞驻留因子CD103的上调。
- 靶向MMP2和CD100的抑制剂在咪喹莫特诱导的银屑病模型中有效减轻炎症。
临床怎么用
- 靶向MMP2或CD100可能成为减轻银屑病炎症和复发的潜在治疗策略。
- 关注高表达MMP2的成纤维细胞与CD8+ T细胞驻留的相互作用,可能有助于解释银屑病复发机制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Psoriasis is a T cell-mediated chronic inflammatory skin condition characterized by the interaction of T cells with various cell types, forming an inflammatory microenvironment that sustains psoriatic inflammation. Homeostasis of these tissue-resident T cells is supported by fibroblasts, the primary structural cells in the dermis. In psoriasis, there is increased expression of matrix metalloproteinase 2 (MMP2), mediating structural alterations in skin tissues and modulating inflammation. Additionally, the CD100-plexin-B2 (PLXNB2) axis is known to enhance psoriasis inflammation via keratinocytes, and CD103 levels are associated with the severity of psoriasis upon relapse. OBJECTIVES: To elucidate the role of fibroblasts and the MMP2-CD100 axis in modulating psoriasis inflammation. METHODS: CD100 expression and function in psoriasis were assessed using immunofluorescence, enzyme-linked immunosorbent assay, single-cell transcriptome sequencing, cellular interaction analyses and quantitative reverse transcriptase polymerase chain reaction. CD8+ T cells from people with psoriasis were isolated using magnetic beads, to investigate the regulatory effect of MMP2 on CD100 expression on their membranes. Single-cell transcriptome sequencing, spatial transcriptome sequencing, mimetic timing analysis, immunofluorescence and flow cytometry were used to determine the origin of MMP2 and its impact on CD103+ CD8+ T cells. The hypotheses were further validated in vivo using MMP2 and CD100 inhibitors. RESULTS: Soluble CD100 (sCD100) was significantly upregulated in both psoriatic lesions and peripheral blood, amplifying psoriasis inflammation by promoting the production of inflammatory cytokines by keratinocytes, fibroblasts and endothelial cells via the sCD100-PLXNB2 axis. Fibroblasts that highly expressed MMP2 (MMP2hi) exacerbated psoriasis symptoms by facilitating CD100 shedding from CD8+ T-cell membranes. Additionally, it was shown that fibroblasts enhance the upregulation of the CD8+ T-cell residency factor CD103 in co-cultures with CD8+ T cells. Inhibitors targeting MMP2 and CD100 were effective in reducing inflammation in an imiquimod-induced psoriasis model. CONCLUSIONS: Our findings underscore the pivotal role of MMP2hi fibroblasts in the amplification and recurrence of inflammatory responses in psoriasis. These fibroblasts augment psoriasis inflammation through the CD100-PLXNB2 axis by facilitating CD100 shedding on CD8+ T-cell membranes and by upregulating CD103, thereby enhancing CD8+ T-cell residency. Psoriasis is a chronic skin condition. It involves the interaction of cells of the immune system (called T cells) with other cells in the body, causing inflammation. The main structural cells in the skin are called fibroblasts. Fibroblasts are important in skin healing and disease. In psoriasis, the body produces more of an enzyme called MMP2. MMP2 brings about structural alterations in skin tissues and controls inflammation. Proteins called CD100 and PLXNB2 increase the inflammation in psoriasis through another type of skin cell called keratinocytes. We investigated the role of fibroblasts and MMP2 and CD100 in psoriasis. To do this, the production and function of CD100 were assessed using a variety of laboratory techniques. We found that by controlling the enzymes MMP2 and MMP9, fibroblasts cause the release of CD100 from some T cells, encouraging the production of substances that promote inflammation, worsening psoriasis. This also caused fibroblasts to produce more MMP2, forming a cycle that increases the inflammation seen in psoriasis. Fibroblasts were found to increase the level of another protein called CD103 on some T cells, affecting how often psoriasis flares up. Our study highlights the important role of fibroblasts that express a lot of MMP2 in the inflammation found in people with psoriasis.
引用
- Dong C, Lin JM, Lu X, et al. Fibroblasts with high matrix metalloproteinase 2 expression regulate CD8+ T-cell residency and inflammation via CD100 in psoriasis. Br J Dermatol. 2024. PMID: 38752329. doi:10.1093/bjd/ljae205
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。